Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Meanwhile, Abbott's FreeStyle Libre and FreeStyle Libre 2 flash CGM systems remain available to patients and listed on the NHS Drug Tariff. The FreeStyle Libre 3 system consists of the sensor ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially available in five more ...

Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the ...

Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] Abbott (NYSE:ABT) announced today that it reached an agreement with Dexcom (Nasdaq:DXCM) to settle all ...

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...

Corporation announced the Omnipod 5 Automated Insulin Delivery System is now commercially available in five more ...

Freestyle Libre CGM device is also on a great trajectory. Abbott currently has partnerships ... its new glucose monitoring sensor available for purchase without a prescription.

Android application which receives Glucose values from multiple sources and provide Wear OS complications, Android Auto support, phone widgets/notifications and Tasker integration.